hydroxychloroquine has been researched along with Cerebral Hemorrhage in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Cerebral Hemorrhage: Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We examined the effect of an immunomodulator hydroxychloroquine, also known as a Nurr1 ligand and an autophagy inhibitor, on a mouse model of intracerebral hemorrhage (ICH)." | 8.12 | Hydroxychloroquine improves motor function and affords neuroprotection without inhibition of inflammation and autophagy in mice after intracerebral hemorrhage. ( Ichihara, Y; Katsuki, H; Kinoshita, K; Kurauchi, Y; Seki, T; Yoshimizu, A, 2022) |
| "We examined the effect of an immunomodulator hydroxychloroquine, also known as a Nurr1 ligand and an autophagy inhibitor, on a mouse model of intracerebral hemorrhage (ICH)." | 4.12 | Hydroxychloroquine improves motor function and affords neuroprotection without inhibition of inflammation and autophagy in mice after intracerebral hemorrhage. ( Ichihara, Y; Katsuki, H; Kinoshita, K; Kurauchi, Y; Seki, T; Yoshimizu, A, 2022) |
| "A 47-year-old woman with history of seizure disorder (semiology of seizure unknown), not well controlled with antiepileptic drugs since last 30 years presented with 1-year history of intermittent throbbing headache." | 1.62 | Moyamoya angiopathy unmasking systemic lupus erythematosus. ( Das, S; Dubey, S; Pandit, A; Ray, BK, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshimizu, A | 1 |
| Kinoshita, K | 1 |
| Ichihara, Y | 1 |
| Kurauchi, Y | 1 |
| Seki, T | 1 |
| Katsuki, H | 1 |
| Das, S | 1 |
| Dubey, S | 1 |
| Pandit, A | 1 |
| Ray, BK | 1 |
2 other studies available for hydroxychloroquine and Cerebral Hemorrhage
| Article | Year |
|---|---|
Hydroxychloroquine improves motor function and affords neuroprotection without inhibition of inflammation and autophagy in mice after intracerebral hemorrhage.
Topics: Animals; Autophagy; Brain; Cerebral Hemorrhage; Hydroxychloroquine; Inflammation; Male; Mice; Mice, | 2022 |
Moyamoya angiopathy unmasking systemic lupus erythematosus.
Topics: Albuminuria; Angiography, Digital Subtraction; Antibodies, Antinuclear; Anticonvulsants; Antirheumat | 2021 |